Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tezacaftor/ivacaftor
tezacaftor/ivacaftor
FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
Endpoints
Tue, 08/20/19 - 12:43 pm
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
tezacaftor/ivacaftor
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Motley Fool
Wed, 06/12/19 - 09:45 am
Vertex Pharmaceuticals
VX-445
tezacaftor/ivacaftor
AbbVie
upadacatinib
Daiichi Sankyo
trastuzumab deruxtecan
Celgene
liso-cel
Novartis
LY3298176
Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly
Endpoints
Mon, 08/13/18 - 11:18 am
Vertex Pharmaceuticals
NICE
cystic fibrosis
Symkevi
tezacaftor/ivacaftor
Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Yahoo/Zacks.com
Sat, 08/26/17 - 07:41 pm
Vertex Pharmaceuticals
cystic fibrosis
FDA
priority review
EMA
tezacaftor/ivacaftor
Kalydeco